Australian Society of Plastic Surgeons Seeks Medicare Rebates for Gender-Affirming Surgeries

The Australian Society of Plastic Surgeons (ASPS) has submitted a proposal to expand Medicare rebates to cover more than 30 types of gender reassignment surgeries, a move that could significantly reduce out-of-pocket expenses for transgender individuals in Australia. The proposal is currently under consideration by the Medical Services Advisory Committee (MSAC), which advises the government on public funding for medical services.

Currently, many individuals seeking gender-affirming surgeries face substantial costs, with procedures like vaginoplasty potentially costing up to $60,000 and facial feminisation surgery up to $80,000. The ASPS is seeking new Medicare item numbers for consultations before and after surgery, as well as for specific procedures including chest masculinisation, breast augmentation, hysterectomy, removal of ovaries or testes, vaginoplasty, phalloplasty, metoidioplasty, and facial feminisation surgery.

The proposed changes aim to establish a clearer and more consistent pathway for adults seeking gender-affirming surgical care. The ASPS estimates that over 128,000 transgender Australians could be candidates for these medical interventions. In the first full year if approved, an estimated 47,087 people are expected to utilize these services.

Supporters of the proposal argue that these procedures are vital for improving the quality of life and mental health outcomes for transgender and gender-diverse individuals, who experience higher rates of depression, anxiety, and suicidality. The ASPS notes that medical and surgical interventions are often a crucial part of their care.

However, MSAC has requested a more comprehensive review of the clinical evidence, stating that the initial submission did not adequately cover all relevant information according to its guidelines. A more robust assessment of the effectiveness and safety of gender-affirming surgery is required before the application can proceed. International variations in surgical access, including requirements for psychological assessment and formal diagnoses, were also noted.

MSAC is reviewing the application in two stages: first focusing on clinical evidence and safety, and second on the economic impact and financial implications of public funding. The committee is expected to consider the matter later this year.